221 related articles for article (PubMed ID: 33600992)
21. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Importance of the Lymph Node Factor in Surgically Resected Non-Small Cell Lung Cancer.
Tezel C; Dogruyol T; Alpay L; Akyıl M; Evman S; Metin S; Baysungur V; Yalcinkaya I
Thorac Cardiovasc Surg; 2020 Mar; 68(2):183-189. PubMed ID: 30388719
[TBL] [Abstract][Full Text] [Related]
23. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
25. Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).
Kehl KL; Zahrieh D; Yang P; Hillman SL; Tan AD; Sands JM; Oxnard GR; Gillaspie EA; Wigle D; Malik S; Stinchcombe TE; Ramalingam SS; Kelly K; Govindan R; Mandrekar SJ; Osarogiagbon RU; Kozono D
JAMA Oncol; 2022 May; 8(5):717-728. PubMed ID: 35297944
[TBL] [Abstract][Full Text] [Related]
26. Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer.
Haney JC; Hanna JM; Berry MF; Harpole DH; D'Amico TA; Tong BC; Onaitis MW
J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1164-8. PubMed ID: 24507984
[TBL] [Abstract][Full Text] [Related]
27. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer.
Ahmad U; Crabtree TD; Patel AP; Morgensztern D; Robinson CG; Krupnick AS; Kreisel D; Jones DR; Patterson GA; Meyers BF; Puri V
Ann Thorac Surg; 2017 Jul; 104(1):303-307. PubMed ID: 28433225
[TBL] [Abstract][Full Text] [Related]
29. Robotic resection of Stage III lung cancer: an international retrospective study.
Veronesi G; Park B; Cerfolio R; Dylewski M; Toker A; Fontaine JP; Hanna WC; Morenghi E; Novellis P; Velez-Cubian FO; Amaral MH; Dieci E; Alloisio M; Toloza EM
Eur J Cardiothorac Surg; 2018 Nov; 54(5):912-919. PubMed ID: 29718155
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.
Fan C; Gao S; Hui Z; Liang J; Lv J; Wang X; He J; Wang L
Radiat Oncol; 2013 Dec; 8():286. PubMed ID: 24321392
[TBL] [Abstract][Full Text] [Related]
33. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
[TBL] [Abstract][Full Text] [Related]
34. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
35. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer.
Osaki T; Nagashima A; Yoshimatsu T; Tashima Y; Yasumoto K
Lung Cancer; 2004 Feb; 43(2):151-7. PubMed ID: 14739035
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer.
Park SY; Lee JG; Kim J; Byun GE; Bae MK; Lee CY; Kim DJ; Chung KY
J Cardiothorac Surg; 2013 Jun; 8():151. PubMed ID: 23759129
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
39. A Risk Model to Predict the Delivery of Adjuvant Chemotherapy Following Lung Resection in Patients With Pathologically Positive Lymph Nodes.
Patella M; Brunelli A; Adams L; Cafarotti S; Costardi L; De Leyn P; Decaluwé H; Franks KN; Fuentes M; Jimenez MF; Karri S; Moons J; Novellis P; Ruffini E; Veronesi G; Voulaz E; Shargall Y
Semin Thorac Cardiovasc Surg; 2023; 35(2):387-398. PubMed ID: 35272025
[TBL] [Abstract][Full Text] [Related]
40. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.
Wang EH; Corso CD; Park HS; Chen AB; Wilson LD; Kim AW; Decker RH; Yu JB
Am J Clin Oncol; 2018 Feb; 41(2):152-158. PubMed ID: 26523443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]